THNK:CC - Think Research Announces Date of First Quarter 2022 Earnings Release and Conference Call Details

Canada NewsWire

Earnings to be announced by the Company before market opens on May 30, 2022

TORONTO , May 26, 2022 /CNW/ - Think Research Corporation (TSXV: THNK) (OTC: THKKF) ("Think" or the "Company"),  a company focused on transforming healthcare through digital health software solutions, today announced that it will release its financial results for the three months ended March 31, 2022 before the market opens on May 30, 2022 .

Think's financial statements and Management Discussion and Analysis will be available under the Company's profile on SEDAR and on the Company's website as of 7:30 a.m. Eastern Time .

Management will hold a conference call on May 30, 2022 at 9 a.m. Eastern Time hosted by CEO Sachin Aggarwal and interim CFO John Hayes with a Q&A session to follow.

Conference call dial-in:
Toronto : 416-764-8659
North American Toll-free: 1-888-664-6392
Conference ID: 11593959
Webcast: https://produceredition.webcasts.com/starthere.jsp?ei=1551355&tp_key=9f0d8e674c

A transcript of the call will be posted on the Company's website at www.thinkresearch.com within 48 hours of the call.

Think Research Corporation is an industry leader in delivering knowledge-based digital health software solutions. The Company's focused mission is to organize the world's health knowledge so everyone gets the best care. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes. For over a decade, Think's cloud-based, EMR- agnostic digital tools have empowered clinicians around the world and positively impacted millions of patients across the continuum of care – including primary physician care, acute care hospitals and surgical suites as well as community and seniors care. Think is proud to serve as a trusted health system partner to a rapidly growing, global client base that spans five continents across more than 13,000 healthcare facilities, with a clinical audience of over 300,000 doctors, nurses and pharmacists. Visit www.thinkresearch.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information: https://www.thinkresearch.com/ca/investors/

SOURCE Think Research Corporation

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2022/26/c6828.html